Just Other Articles

Debt restructuring refers to the reallocation of resources or change in the terms of loan extension to enable the debtor to pay back the loan to his

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

or her creditor. Debt restructuring is an adjustment made by both the debtor and the creditor to smooth out temporary difficulties in the way of lo

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

an repayment. Debt restructuring is of two types, and there are many ways to carry out the restructuring process.

Debt Restructuring: Types

Debt r

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

structuring is of two kinds, depending on the terms and the cost to the debtor.

1) General Debt Restructuring Under the terms of general debt rest

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ructuring, the creditor incurs no losses from the process. This happens when the creditor decides to extend the loan period, or lowers the interest

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

rate, to enable the debtor to tide over temporary financial difficulty and pay the debt later.

2) Troubled Debt Restructuring Troubled debt restru

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

turing refers to the process where the creditor incurs losses in the process. This happens when the Debt Restructuring leads to reduction in the acc

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

rued interest, or due to the dip in the value of the collateral, or through conversions to equity.

How to Plan Debt Restructuring:

1) The creditin

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

g company should prepare a roadmap for the debt restructuring process. The strategy should include the expected time to be taken to recover the debt

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

, the terms of loan repayment, and watching the financial performance of the debtor.

2) The decision of the financial institution regarding Debt Re

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

structuring depends on whether the debtor has invested in the company, holds shares with the company, or is a subsidiary of the company.

3) If ther

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

e is conflict within the company’s board of directors regarding the process, then it is advisable to ask for help from a third party. However, third

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

party mediation is not needed if the debtor is a subsidiary of the company.

4) Making a cash flow projection is also important to the Debt Restruct

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

uring process. It is advisable not to include uncertain cash flow estimates in the plan.

5) The debtor’s financial situation should also be conside

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

red while making a Debt Restructuring plan. The debtor’s ability to repay the loan depends on his or her financial management, so the financial comp

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ny needs to look into the debtor’s roadmap for repaying the loan. If the debtor is another company, then changing the key people associated with it,

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

like the director, board of directors or chairperson might help.

If you are planning to go for Debt Restructuring, as a creditor or borrower, you

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

can approach a small business consultant for help.

Debt restructuring depends on many factors like the debtor’s financial management, the projected

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

cash inflow, the relation between the debtor and the creditor etc. Debt Restructuring is meant to help both the parties. It involves compromises mad

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

e by the creditor as well as the debtor to ensure that the loan is repaid in full to the creditor without too much of a financial loss to the debtor

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/89724/justotherarticles-Debt-Restructuring-Types-And-Methods.html">Debt Restructuring: Types And Methods</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/89724/justotherarticles-Debt-Restructuring-Types-And-Methods.html]Debt Restructuring: Types And Methods[/url]

You wouldn't expect the President of Customersatisfaction.com, popular keynote speaker and best-selling author, Dr. Gary S. Goodman, to say surveys suck. But he gives five reasons for doubting their validity and the motivations of those who use them as devices to determine customer satisfaction.

As you probably know by now, keyword research is the key, pun intended, to getting rankings that produce traffic for your site. That being said, not all keywords carry the same value.

SEO and Search Engine Optimization Services have become a pretty big deal in the past year or so. But has this really been a good thing? Compared to the past it appears that it is a good thing but at what cost? The Time and Cost elements are the crucial components. Is your webmaster ready for the dedicated amount of work?

Tags

Links

Just Other Articles - Debt Restructuring: Types And Methods

Related Articles: